Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

• Status: Unknown status
• Trial end date: 2012-10-01

Summary

The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Bromfenac; Fluoroquinolones; Loteprednol Etabonate; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Polystyrene sulfonic acid; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate